HRP20080253T3 - Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives - Google Patents

Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives

Info

Publication number
HRP20080253T3
HRP20080253T3 HR20080253T HRP20080253T HRP20080253T3 HR P20080253 T3 HRP20080253 T3 HR P20080253T3 HR 20080253 T HR20080253 T HR 20080253T HR P20080253 T HRP20080253 T HR P20080253T HR P20080253 T3 HRP20080253 T3 HR P20080253T3
Authority
HR
Croatia
Prior art keywords
formula
compound
carbon atoms
isoindol
dihydro
Prior art date
Application number
HR20080253T
Other languages
English (en)
Croatian (hr)
Inventor
Schubert Gerrit
Rieke-Zapp Joerg
Keil Johannes
Kleemann Heinz-Werner
Hanna Reda
Huang Bao-Guo
Wu Xiao-Dong
Gouraud Yves
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20080253T3 publication Critical patent/HRP20080253T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HR20080253T 2003-12-02 2004-11-19 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives HRP20080253T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10356717A DE10356717A1 (de) 2003-12-02 2003-12-02 Verfahren zur Herstellung von (3-Oxo-2,3-dihydro-1H-isoindol-1-yl)-acetylguanidin-Derivaten

Publications (1)

Publication Number Publication Date
HRP20080253T3 true HRP20080253T3 (en) 2008-09-30

Family

ID=34638338

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080253T HRP20080253T3 (en) 2003-12-02 2004-11-19 Method for producing (3-oxo-2,3-dihydro-1h-isoindol-1-yl) acetylguanidine derivatives

Country Status (37)

Country Link
EP (1) EP1692105B1 (sr)
JP (1) JP4809774B2 (sr)
KR (1) KR101202604B1 (sr)
CN (1) CN100526297C (sr)
AR (1) AR046733A1 (sr)
AT (1) ATE395334T1 (sr)
AU (1) AU2004295056B2 (sr)
BR (1) BRPI0417147A (sr)
CA (1) CA2548020C (sr)
CR (1) CR8376A (sr)
CY (1) CY1108187T1 (sr)
DE (2) DE10356717A1 (sr)
DK (1) DK1692105T3 (sr)
EC (1) ECSP066597A (sr)
EG (1) EG25498A (sr)
ES (1) ES2304634T3 (sr)
HR (1) HRP20080253T3 (sr)
IL (1) IL175834A (sr)
JO (1) JO2498B1 (sr)
MA (1) MA28220A1 (sr)
MY (1) MY136467A (sr)
NO (1) NO20063058L (sr)
NZ (1) NZ547625A (sr)
OA (1) OA13293A (sr)
PA (1) PA8618701A1 (sr)
PE (1) PE20051037A1 (sr)
PL (1) PL1692105T3 (sr)
PT (1) PT1692105E (sr)
RS (1) RS50571B (sr)
RU (1) RU2397159C2 (sr)
SI (1) SI1692105T1 (sr)
TN (1) TNSN06167A1 (sr)
TW (1) TWI334348B (sr)
UA (1) UA83883C2 (sr)
UY (1) UY28648A1 (sr)
WO (1) WO2005054195A1 (sr)
ZA (1) ZA200603338B (sr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
WO2009128421A1 (ja) * 2008-04-16 2009-10-22 キッセイ薬品工業株式会社 ピラゾール誘導体の１／２フマル酸塩
RU2518740C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
CN107778238B (zh) * 2016-08-29 2022-07-22 中山大学 一种3，4-二氢异喹啉-1-酮的合成新方法
CN107286074B (zh) * 2017-08-16 2019-08-20 厦门华厦学院 3-羟基异吲哚-1-酮衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
DE19737224A1 (de) * 1997-08-27 1999-03-18 Hoechst Marion Roussel De Gmbh Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
RU2186057C1 (ru) * 2001-03-22 2002-07-27 Аляутдин Ренад Николаевич 4-нитро-3-трифторметил-перфторнонаноиланилид (флустат), способ его получения и фармацевтическая композиция на его основе
WO2002081443A1 (en) 2001-04-09 2002-10-17 Chiron Corporation Novel guanidino compounds
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant

Also Published As

Publication number Publication date
IL175834A (en) 2010-12-30
KR20060111558A (ko) 2006-10-27
PA8618701A1 (es) 2006-07-03
IL175834A0 (en) 2006-10-05
AR046733A1 (es) 2005-12-21
OA13293A (en) 2007-01-31
WO2005054195A1 (de) 2005-06-16
AU2004295056A1 (en) 2005-06-16
NO20063058L (no) 2006-06-30
EP1692105A1 (de) 2006-08-23
JP2007516243A (ja) 2007-06-21
PE20051037A1 (es) 2005-12-29
NZ547625A (en) 2010-01-29
PT1692105E (pt) 2008-07-04
EP1692105B1 (de) 2008-05-14
EG25498A (en) 2012-01-22
DK1692105T3 (da) 2008-08-25
BRPI0417147A (pt) 2007-03-06
ATE395334T1 (de) 2008-05-15
AU2004295056B2 (en) 2011-04-14
HK1097525A1 (zh) 2007-06-29
CN1886374A (zh) 2006-12-27
UA83883C2 (en) 2008-08-26
DE10356717A1 (de) 2005-07-07
RU2397159C2 (ru) 2010-08-20
DE502004007177D1 (de) 2008-06-26
TNSN06167A1 (en) 2007-11-15
MY136467A (en) 2008-10-31
CN100526297C (zh) 2009-08-12
TW200526207A (en) 2005-08-16
JP4809774B2 (ja) 2011-11-09
RS50571B (sr) 2010-05-07
RU2006123410A (ru) 2008-01-10
CR8376A (es) 2007-12-04
PL1692105T3 (pl) 2008-09-30
UY28648A1 (es) 2005-06-30
CA2548020A1 (en) 2005-06-16
ZA200603338B (en) 2007-06-27
MA28220A1 (fr) 2006-10-02
ECSP066597A (es) 2006-10-25
TWI334348B (en) 2010-12-11
ES2304634T3 (es) 2008-10-16
CY1108187T1 (el) 2014-02-12
SI1692105T1 (sl) 2008-08-31
JO2498B1 (en) 2009-10-05
CA2548020C (en) 2013-01-08
KR101202604B1 (ko) 2012-11-19

Similar Documents

Publication Publication Date Title
MEP24208A (en) Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
ATE253581T1 (de) Verfahren zur herstellung von 3,4- alkylendioxythiophen-2,5-dicarbonsäurederivaten
EP1595870A4 (en) PROCESS FOR PRODUCING A PHENYLALANINE DERIVATIVE HAVING A QUINAZOLINEDIONE SKELETON AND INTERMEDIATE THEREOF
DE69929669D1 (de) Zyklische Amidderivate die Cathepsin K hemmen
WO2004085457A3 (en) 17beta-hydroxysteroid dehydrogenase inhibitors
EA200300100A1 (ru) Способ получения производных 4-тиоалкилбромбензола
PE20020524A1 (es) 7-oxo-piridopirimidinas como inhibidores de quinasas
TW200609670A (en) Pyridone azo compound, tautomer thereof, and colorant-containing curable composition, color filter and manufacturing method thereof
CA2289408A1 (en) Corrosion inhibitor compositions
CA2415210A1 (en) Benzoxazole compound, process for producing the same and herbicides
ATE75737T1 (de) Indenothiazolderivate und verfahren zu ihrer herstellung.
DE602004023606D1 (de) Pyridinylpyrazolopyrimidinon-derivate als pde 7 inhibitoren
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
ZA200706393B (en) Novel betullnic acid derivatives A-ring-condensed to a heterocyclic group
TW200518140A (en) Driving electrolyte and electrolytic capacitor using the same
CO5650235A2 (es) Derivados de imidazol
DK0968189T3 (da) Fremgangsmåde til fremstilling af nicotinsyrer
EP1078920A4 (en) Process for producing pyridine derivative through reaction of azametal lacyclo pentadiene with alkyne
DK0906314T3 (da) Optisk spaltning af forbindelse af typen narwedin
JO2433B1 (en) Preparation of heterocyclic lindane landscapes
NZ336220A (en) Endothelin intermediates by asymmetric conjugate addition reaction using a chiral additive
MXPA05009338A (es) 7-alquenilamino-triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que los contienen.
TW200609214A (en) Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as cpla2 inhibitors
EA200700767A1 (ru) Способ получения пиразолов